mRNA |
dacarbazine |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0003 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0003 |
mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0003 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
mRNA |
BRD-K13999467 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0003 |
mRNA |
fingolimod |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0004 |
mRNA |
Cerulenin |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0004 |
mRNA |
Topotecan |
CCLE |
pan-cancer |
AAC |
0.16 |
0.0005 |